Selectin and selectin ligand binding: a bittersweet attraction

AUTOR(ES)

Zollner, Thomas M.

FONTE

American Society for Clinical Investigation

RESUMO

Inhibition of leukocyte migration into target organs has long been an attractive, though challenging, basis for anti-inflammatory strategies. However, to date, the manipulation of leukocyte rolling along blood vessels has not yielded successful new therapies. An important study may now open new avenues in this exciting field of anti-inflammatory therapies by introducing a putative inhibitor of poly-N-acetyllactosamine biosynthesis that affects selectin ligand activity and shows efficacy in a rodent skin inflammation model.

Documentos Relacionados

• Electrostatic steering and ionic tethering in enzyme–ligand binding: Insights from simulations
• Subunit exchange and ligand binding: a new hypothesis for the mechanism of oxygenation of hemoglobin.
• Two by two: The pairings of P-selectin and P-selectin glycoprotein ligand 1
• Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
• Osmotic stress, crowding, preferential hydration, and binding: A comparison of perspectives